peripheral vascular devices Market

The peripheral vascular devices market is projected to reach US$ 17,679.72 million by 2028 from US$ 11,375.13 million in 2021; it is estimated to grow at a CAGR of 6.5% during 2021-2028.

Market Dynamics

The report focuses on market trends and growth drivers, such as the increasing prevalence of hypertension, obesity, smoking, alcoholism, and peripheral vascular diseases. However, the peripheral vascular devices market growth is impeded by the expensive cost of peripheral vascular devices. The risk of developing peripheral vascular diseases is higher in individuals with hypertension, atherosclerosis, smoking, alcoholism, and obesity, resulting in increased demand for peripheral vascular devices.

Market Segmentation

The global peripheral vascular devices market comprises several categories, such as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, and embolization guidewires. The peripheral vascular stents segment is projected to account for the largest market share in 2021. The peripheral transluminal angioplasty balloon catheters segment is expected to grow at the fastest CAGR of 7.5% from 2021 to 2028, due to the increased use of this type of catheter for treating various medical conditions worldwide. The peripheral vascular devices market is divided into several end-user categories, including hospitals and clinics, specialty clinics, ambulatory care centers, and others, with the hospitals and clinics segment holding the largest market share in 2021. This segment is expected to grow at the fastest CAGR of 6.9% from 2021 to 2028, owing to the growing prevalence of peripheral vascular diseases globally.

Regional Overview

In 2021, the World Health Organization (WHO) reported that around 1.13 billion people worldwide had hypertension, a leading cause of premature death. According to the Centers for Disease Control and Prevention (CDC), hypertension was a primary cause in roughly 500,000 deaths in the US in 2018. The British Heart Foundation reported that in 2019, high blood pressure affected approximately 14.4 million people. The World Health Organization (WHO) noted that in 2016, over 1.9 billion adults aged 18 years or older were overweight, and more than 650 million of them were obese. In the US, the Centers for Disease Control and Prevention (CDC) reported that obesity affected 42.4% of the population in 2017-2018, while in the UK, an estimated one in every four adults and one in every five children aged 10 to 11 were affected by obesity in 2019, according to the NHS. Additionally, harmful tobacco use causes approximately six million deaths annually, and 2.5 million deaths result from the excessive use of alcohol worldwide, as per the WHO.

The National Center for Health Statistics, Indian Council of Medical Research, Centers for Disease Control and Prevention (CDC), the National Center for Biotechnology Information (NCBI), Industrial Biotechnology Leadership Forum, and World Health Organization were among the main primary and secondary sources consulted in the preparation of the report on the peripheral vascular devices market.